A federal district court has held that design defect claims against a brand pharmaceutical manufacturer are preempted by federal law. Booker v. Johnson & Johnson, No. 3:12 oe 40000, 2014 WL 5113305 (N ...
The State Human Rights Commission has directed the government to give an explanation on whether the law that doctors should write generic names of drugs instead of branded names is being implemented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback